CAR-T

New study points to why CAR-T therapy may fail in some lymphoma patients
Fierce Biotech
Thu, 02/4/21 - 08:05 pm
CAR-T
lymphoma
Janssen flags accelerated approval milestone in Europe for CAR-T therapy
Biopharma Reporter
Mon, 02/1/21 - 11:04 pm
JNJ
Janssen
CAR-T
EMA
Europe
cilta-cel
FDA blasts Lonza facility in Form 483 that derailed Bristol Myers' plan of liso-cel nod by 2020
Fierce Pharma
Fri, 01/29/21 - 09:57 am
Bristol-Myers Squibb
Celgene
liso-cel
M&A
CAR-T
Bold Predictions for Medtech in 2021
Medical Devices and Diagnostics Industry
Thu, 01/14/21 - 10:32 am
devices
Medtech
COVID-19
remote patient monitoring
telemedicine
home care
digital medicine
artificial intelligence
machine learning
robotic surgery
3D printing
Joe Biden
gene editing
microbiome
CAR-T
Factor Bioscience spins out a new cell therapy player with eyes on the clinic within 2 years
Endpoints
Wed, 01/6/21 - 11:12 pm
Factor Bioscience
cell therapy
MRNA
CAR-T
Autolus buckles down, chopping 20% of staff and seeking partner for a lead CAR-T program
Endpoints
Wed, 01/6/21 - 10:58 am
Autolus Therapeutics
ESMO
CAR-T
diffuse large B-cell lymphoma
layoffs
Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA
Pharmaforum
Tue, 12/22/20 - 10:41 am
JNJ
Janssen
Multiple Myeloma
CAR-T
cilta-cel
FDA
Bristol-Myers Squibb
ide-cel
ASH: Allogene's off-the-shelf CAR-T posts 60% response rate in fiercely competitive BCMA field
Fierce Biotech
Mon, 12/7/20 - 10:48 am
ASH2020
Allogene
CAR-T
Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration
BioSpace
Mon, 12/7/20 - 10:28 am
Bayer
CAR-T
cell therapy
Atara
FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial
Endpoints
Wed, 11/18/20 - 11:03 am
Cellectis
FDA
patient deaths
CAR-T
clinical trials
Multiple Myeloma
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
Endpoints
Wed, 11/4/20 - 10:30 am
JW Therapeutics
IPOs
CAR-T
liso-cel
China
Hong Kong
Juno Therapeutics
WuXi AppTec
CRISPR stock slides as CAR-T death overshadows signs of efficacy
Fierce Biotech
Wed, 10/21/20 - 10:54 am
CRISPR
CRISPR Therapeutics
CAR-T
patient deaths
EdiGene raises $67M to take gene-editing therapies into humans
Fierce Biotech
Tue, 10/13/20 - 11:09 am
EdiGene
gene editing
CAR-T
beta thalassemia
ET-01
ET-02
Poseida shares plunge after death in solid tumor CAR-T trial, clinical hold
Fierce Biotech
Tue, 08/18/20 - 11:05 pm
Poseida Therapeutics
solid tumors
CAR-T
SEC
prostate cancer
Juno joint venture seeks IPO haul to bring CAR-Ts to China
Fierce Biotech
Mon, 08/17/20 - 10:33 am
JW Therapeutics
Juno Therapeutics
WuXi AppTech
IPOs
Hong Kong
CAR-T
Novartis says CAR-T cancer therapy works in second lymphoma type
BioPharma Dive
Tue, 08/4/20 - 12:40 pm
Novartis
Kymriah
follicular lymphoma
CAR-T
FDA approves MorphoSys, Incyte’s drug for vulnerable lymphoma population
MedCity News
Mon, 08/3/20 - 10:14 am
FDA
Monjuvi
CAR-T
MorphoSys
Incyte
diffuse large B-cell lymphoma
Gilead’s Kite gains some height after second CAR-T approval in US
Pharmaforum
Tue, 07/28/20 - 10:57 am
Gilead Sciences
Kite Pharma
CAR-T
Gilead’s Kite Pharma gets FDA nod for second CAR-T cell therapy
MedCity News
Sat, 07/25/20 - 02:29 pm
Gilead Sciences
CAR-T
KTE-X19
Tecartus
FDA
Kite Pharma
Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold
Fierce Biotech
Tue, 07/7/20 - 10:39 am
Cellectis
CAR-T
UCARCS1A
Multiple Myeloma
patient deaths
FDA

Pages